IV Cocaine Abuse: A Laboratory Model - 3 - Tabular View

Tracking Information

First Received Date ^ICMJE

September 20, 1999

Last Updated Date

June 23, 2005

Start Date ^ICMJE

January 1992

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Direct cocaine effects (caridio, subjective)
Interaction of coc/bup on cardio measures
Ineraction of coc/bup on coc's subjective effects
Effects of buprenorphine on cocaine craving

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00000214 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

IV Cocaine Abuse: A Laboratory Model - 3

Official Title ^ICMJE

IV Cocaine Abuse: A Laboratory Model

Brief Summary

The purpose of this study is to evaluate the effects of buprenorpine on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving in non-opiate dependent cocaine users.

Detailed Description

Study Phase

Phase II

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment

Condition ^ICMJE

Cocaine-Related Disorders

Intervention ^ICMJE

Drug: Buprenorphine

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

Primary Completion Date

Eligibility Criteria ^ICMJE

Please contact site for information.

Gender

Both

Ages

18 Years to 45 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00000214

Responsible Party

Study ID Numbers ^ICMJE

NIDA-06234-3, R01-06234-3

Study Sponsor ^ICMJE

National Institute on Drug Abuse (NIDA)

Collaborators ^ICMJE

Columbia University

Investigators ^ICMJE

Principal Investigator:

Richard Foltin, Ph.D.

Columbia University

Information Provided By

National Institute on Drug Abuse (NIDA)

Verification Date

May 1992

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP